mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.32 |
0.3 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.3 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |